AMW GmbH, a German pharmaceutical company specialized in the development and manufacturing of innovative drug delivery systems, received €25m.
The European Investment Bank (EIB) will provide the financing.
The funds will support the company in Warngau, Bavaria, and its subsidiary Endomedica in Halle, Saxony-Anhalt, enabling them to increase R&D activities, conduct clinical trials and expand production capacity. This will be achieved with a new building located at the head office in Warngau to house research, development and production facilities complimented by purpose-built manufacturing technology and state-of-the-art laboratory equipment.
Led by Dr Wilfried Fischer, Founder and Managing Director, AMW is a specialty pharmaceuticals company located in Warngau near Munich, Germany. Its R&D expertise is focused on drug delivery systems, especially biodegradable implants and transdermal delivery systems.